Recognition must work at the first encounter.
Why prescription checks and continuing treatment belong together.
A lawful medicine should come with usable care and accountable decisions.
Justice by Design examines how law, policy and institutional practice affect people using prescribed cannabis medicine.
The ban was disclosed. Its new criminal burden within lawful treatment was presented as continuity.
What officials knew.
What ministers chose.
What Parliament was told.
Private prescription items for unlicensed cannabis medicines, dispensed in England on prescriptions dated 2025.
An item records a product appearing on a prescription form. NHSBSA’s separate response explains why it cannot reliably count distinct private patients.
Explore the figures and their limitsA clinician needs to know how medicine is actually used. Fear of criminal exposure or losing treatment can put pressure on that conversation.
Can I explain what happens without fear of losing appropriate care?
Can I hear an accurate account, review the reasons and agree a workable plan?
The report examines the legal and professional pressures around disclosure and continuing care.
Follow the clinical evidenceChoose the priorities that matter to you. Each audience has its own route through the wider research.
Who advised, decided and explained the rule—and when the records became available.
Follow the decisionsSee how prescribing, regulation, enforcement and continuing care meet.
Explore the systemDifferent sources establish different parts of the argument.
Explore the evidence mapA last resort medicine and an additional crime.
The law, ministerial decision and institutional record behind the extra offence for smoking lawfully prescribed cannabis medicine.
Source explainers, ongoing questions and substantive developments.
Why prescription checks and continuing treatment belong together.
Requests, departmental responses and the question left open by cost refusals.
Follow the correspondenceHow the latest report connects immediate protection with legal reform.
Read the briefingQuestions, observations and conversations from Justice by Design.
JBD calls for a wider discussion about clinically supported access to cannabis medicines.
Read on LinkedInQuestions about industry regulation, patient access and the distinctions that matter.
Read on LinkedInJBD welcomes work to help prescribed patients navigate stigma and unequal treatment.
Read on LinkedIn